.According to a new market research report “ Biosurgery Market by Product (fibrin & Collages Sealant, Hemostats, Adhesion Barriers, Biological Meshes, soft tissue attachments, forklifts, Bone Graft Substitutes) Application (Orthopedic, Gynecology, Cardiovascular, Reconstructive) – Forecast to 2023 „ , published by MarketsandMarkets ™, the market is expected to reach USD 15:58 trillion by 2023 from at estimated USD 11:36 trillion in 2018, at a CAGR of 6.5%.
Browse 352 market data Tables and 56 Figures spread through 314 Pages and in-depth TOC on „Biosurgery Market“.
https://www.marketsandmarkets.com/Market-Reports/biosurgery-market-166922302.html
Early buyers will receive 10% customization on this report
Currently, the global biosurgery market is driven by the rising geriatric population, increasing in the volume of surgeries and sports-related and trauma injuries, increasing clearance of biosurgery products by regulatory authorities and growing need for effective blood loss management in patients. However, the high price of biosurgery products and the cost of these procedures may be limited during the period under review.
The bone-graft substitutes segment accounted for the largest share of the Biosurgery Market in 2017
On the basis of product, the biosurgery is broadly segmented into bone-graft substitutes, soft tissue attachments, hemostatic agents, surgical sealants & adhesives, adhesion barriers, and staple-line agents. In 2017, the bone-graft substitutes segment accounted for the largest share of this market. By surgeons in various surgeries (as compared to other biosurgery products). Advantages such as cost-effectiveness, biocompatible, bioresorbable, osteoconductive, and osteoinductive properties of bone-graft substitutes make them more preferred as compared to other biosurgery products.
The reconstructive surgeries segment is expected to register the highest CAGR during the periodic
analysis on applications, the Biosurgery Market is segmented into gynecological surgeries, general surgeries, cardiovascular surgeries, orthopedic surgeries, neurological surgeries, reconstructive surgeries, urological surgeries, and thoracic surgeries. The reconstructive surgeries segment is estimated to be the highest CAGR during the forecast period. The growth of this segment is driven by the increasing focus of players on developing surgical sealants for reconstructive surgeries.
Ask for PDF Brochure @ https://www.marketsandmarkets.com/pdfdownload.asp?id=166922302
North America dominated the market in 2017
North America accounted for the largest share of the Biosurgery Market in 2017, followed by Europe. Increase in the incidence of chronic disease associated with aging population, increase in the volume of surgical procedures, well-established healthcare services, higher public and private healthcare expenditures, and adoption of highly advanced technology Biosurgery Market.
The key players in the global Biosurgery market are Johnson & Johnson (US), Sanofi (France), Baxter (US), CR Bard (US), Integra Life Sciences (US), MAQUET (Sweden), Medtronic (Ireland), Cohera Medical (US), Hemostasis (US), Stryker (US), B. Braun (Germany), CSL (Australia), Pfizer (US), and CryoLife (US).